Epsilon M&A Deal Report - I2a (Intelligence Articielle Application)
Transaction Multiples for the Valuation of Private Companies
Private Group led by Apposite Capital / I2a (Intelligence Articielle Application)
No EMAT :
121527
Announced Date :
31/07/2021
Type :
MBI (Management Buy In) ,Exit
Deal Value :
Yes
Acquirer :
Private Group led by Apposite Capital
Target :
I2a (Intelligence Articielle Application)
Country :
France
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
- Specialized Software > Business Software > Software > Medical Software
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 1988 by Jean-Philippe Duvergé and Dominique Curel , I2a (Intelligence Artificielle Application) is a specialist in microbiological diagnostics, particularly in automated antibiogram...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | ns | ns | ns | ns | |
| Current |
|
ns | ns | ns | ns | ns |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 46
- Number of EMAT Reports / sub-sector « Medical Software » = 94
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 40
| Date | Acquirer | Target | Country | Multiples | See details |
| 30/09/2022 | Veranex Group | Devicia & Clarvin | Sweden | *** | 121276 |
| 22/01/2020 | ICON | MedPass International | France | ** | 121267 |
Source: Epsilon Research / EMAT
